These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15209077)

  • 21. Efficacy trials for HIV/AIDS vaccines.
    Petricciani JC; Koff WC; Ada GL
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1527-9. PubMed ID: 1466997
    [No Abstract]   [Full Text] [Related]  

  • 22. NIAID HIV/AIDS vaccine research. National Institute of Allergy and Infectious Diseases.
    NIAID AIDS Agenda; 1997 Aug; ():4. PubMed ID: 11364611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AIDS vaccine research in Asia: needs and opportunities. Report from a UNAIDS/WHO/NIID meeting Tokyo, 28-30 October 1998.
    AIDS; 1999 Jul; 13(11):UNAIDS 1-UNAIDS 13. PubMed ID: 10449273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Funding support lacking in search for HIV vaccine.
    AIDS Alert; 1999 Jan; 14(1):5-7. PubMed ID: 11366091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accelerating the development of an AIDS vaccine: the AIDS vaccine for Asia Network (Avan).
    Pitisuttithum P; Rerks-Ngarm S; Chiu J; Kim J; Benenson M; Kent SJ; Tamashiro H; Manrique A; Bernstein A; Goyal R; Ditangco RA; Cooper DA; Osmanov S; Mathieson B; Sandstrom E; Esparza J; Hoff R; Shao Y;
    Southeast Asian J Trop Med Public Health; 2011 Sep; 42(5):1130-46. PubMed ID: 22299439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preparations for AIDS vaccine evaluations. AIDS International Training and Research Program.
    Bridbord K
    AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S227-9. PubMed ID: 7865307
    [No Abstract]   [Full Text] [Related]  

  • 27. Defining the objectives of the AIDS vaccine for Asia network: report of the WHO-UNAIDS/Global HIV vaccine enterprise regional consultation on expanding AIDS vaccine research and development capacity in Asia.
    Rerks-Ngarm S; Pitisuttithum P; Ganguly N; Zhang L; Tamashiro H; Cooper DA; Vun MC; Bela B; Ditangco R; Van Kinh N; Bernstein A; Osmanov S; Mathieson B; Kent SJ; Shao Y
    Curr Opin HIV AIDS; 2010 Sep; 5(5):435-52. PubMed ID: 20978386
    [No Abstract]   [Full Text] [Related]  

  • 28. The impact of an AIDS vaccine in developing countries: a new model and initial results.
    Stover J; Bollinger L; Hecht R; Williams C; Roca E
    Health Aff (Millwood); 2007; 26(4):1147-58. PubMed ID: 17630459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The global HIV vaccine enterprise.
    Esparza J
    Int Microbiol; 2005 Jun; 8(2):93-101. PubMed ID: 16052457
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV/AIDS. The great funding surge.
    Cohen J
    Science; 2008 Jul; 321(5888):512-9. PubMed ID: 18653876
    [No Abstract]   [Full Text] [Related]  

  • 31. Search for AIDS vaccine at risk because of lack of interest and funding.
    AIDS Read; 2005 Oct; 15(10):497. PubMed ID: 16265764
    [No Abstract]   [Full Text] [Related]  

  • 32. HIV vaccine development for the world: an idea whose time has come?
    Berkley S
    AIDS Res Hum Retroviruses; 1998 Oct; 14 Suppl 3():S191-6. PubMed ID: 9814943
    [No Abstract]   [Full Text] [Related]  

  • 33. Grappling with global concerns in the search for an HIV vaccine.
    Grady C
    J Assoc Nurses AIDS Care; 1999; 10(1):17-20. PubMed ID: 9934666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Scientific considerations for the regulation and clinical evaluation of HIV/AIDS preventive vaccines: report from a WHO-UNAIDS Consultation 13-15 March 2001, Geneva, Switzerland.
    AIDS; 2002 Jul; 16(10):W15-25. PubMed ID: 12131232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Good enough to use for research, but not good enough to benefit from the results of that research: are the clinical HIV vaccine trials in Africa unjust?
    Yearby R
    De Paul Law Rev; 2004; 53(3):1127-54. PubMed ID: 16200692
    [No Abstract]   [Full Text] [Related]  

  • 36. The challenges of HIV vaccine development and testing.
    Burgers WA; Williamson C
    Best Pract Res Clin Obstet Gynaecol; 2005 Apr; 19(2):277-91. PubMed ID: 15778116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prior agreements in international clinical trials: ensuring the benefits of research to developing countries.
    Page AK
    Yale J Health Policy Law Ethics; 2002; 3(1):35-66. PubMed ID: 12825426
    [No Abstract]   [Full Text] [Related]  

  • 38. The future of HIV vaccine research and the role of the Global HIV Vaccine Enterprise.
    Voronin Y; Manrique A; Bernstein A
    Curr Opin HIV AIDS; 2010 Sep; 5(5):414-20. PubMed ID: 20978383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Africa matters.
    Clinton WJ
    AIDS Patient Care STDS; 2000 Dec; 14(12):619-20. PubMed ID: 11119427
    [No Abstract]   [Full Text] [Related]  

  • 40. Executive summary and recommendations from WHO/UNAIDS and AAVP consultation on: 'The inclusion of adolescents in HIV vaccine trials', 16-18 March 2006 in Gaborone, Botswana.
    ; Osmanov S
    AIDS; 2007 Sep; 21(14):W1-10. PubMed ID: 17721089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.